IBM Investor Steigerwald Gordon & Koch Trims Stake

Institutional investor reduces holdings in tech giant by 2.4% in Q4 2025

Apr. 12, 2026 at 10:40am

Got story updates? Submit your updates here. ›

A highly detailed, cinematic close-up image of complex, heavy industrial banking machinery and equipment in shades of gunmetal grey, steel blue, and black, conveying a sense of institutional financial security and stability through its tangible, physical presence.An extreme close-up of IBM's enterprise computing hardware highlights the company's role as a foundational pillar of the global financial system.Armonk Today

Steigerwald Gordon & Koch Inc., a major institutional investor, decreased its stake in shares of International Business Machines Corporation (NYSE:IBM) by 2.4% in the fourth quarter of 2025, according to a recent SEC filing. The firm still holds a significant $28.64 million position in IBM stock, making it one of the company's largest shareholders.

Why it matters

This filing provides insight into the investment strategies of major institutional players and could signal broader market sentiment around IBM's stock performance and future outlook. Tracking changes in large investor positions is a key indicator for financial analysts and industry watchers.

The details

According to the 13F filing, Steigerwald Gordon & Koch Inc. sold 2,381 shares of IBM stock during the fourth quarter, reducing its total position to 96,671 shares. The firm's IBM holdings now make up about 2.7% of its overall investment portfolio.

  • Steigerwald Gordon & Koch Inc. filed the 13F report for the fourth quarter of 2025 on April 12, 2026.
  • The firm decreased its IBM stake by 2.4% during the October-December 2025 period.

The players

Steigerwald Gordon & Koch Inc.

A major institutional investment firm that owns a significant stake in IBM stock.

International Business Machines Corporation (IBM)

A global technology and consulting company headquartered in Armonk, New York.

Got photos? Submit your photos here. ›

The takeaway

This filing highlights the ongoing shifts in institutional investor sentiment around IBM as the company navigates industry changes and competitive pressures. The reduction in Steigerwald Gordon & Koch's position, while relatively small, could signal broader caution among some major shareholders about IBM's near-term prospects.